Purchases and Sales Made in Q3 2024 in Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE) during Q3 2024. The information is specifically focused on institutions that hold shares of Sage Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 28, 2024
Q3 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-9.6K- 44.35% |
$67.4K - $126K
|
12K
$66K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-10K- 12.2% |
$70.4K - $131K
|
72.1K
$395K
|
|
|
Nov 13, 2024
Q3 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-12.2K- 10.5% |
$85.8K - $160K
|
104K
$571K
|
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-20K- 3.93% |
$141K - $262K
|
489K
$2.68M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-20.5K- 8.29% |
$144K - $269K
|
227K
$1.25M
|
|
|
Nov 12, 2024
Q3 2024
|
Fox Run Management, L.L.C.
Greenwich, CT |
SELL
|
- |
-24.4K- 59.82% |
$171K - $319K
|
16.4K
$89.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
SELL
|
- |
-26.6K- 61.2% |
$187K - $348K
|
16.8K
$92.3K
|
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-30.2K- 20.05% |
$212K - $395K
|
120K
$660K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-40.1K- 7.25% |
$281K - $524K
|
513K
$2.81M
|
|
|
Oct 18, 2024
Q3 2024
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-48.6K- 99.59% |
$341K - $636K
|
198
$1.09K
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-51.1K- 23.99% |
$358K - $668K
|
162K
$887K
|
|
|
Nov 12, 2024
Q3 2024
|
Cowen And Company, LLC
|
SELL
|
- |
-53K- 24.76% |
$372K - $694K
|
161K
$883K
|
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-60.7K- 22.09% |
$426K - $794K
|
214K
$1.17M
|
|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-62.2K- 12.13% |
$437K - $814K
|
451K
$2.47M
|
|
|
Nov 14, 2024
Q3 2024
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-62.3K- 26.69% |
$438K - $816K
|
171K
$939K
|
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-68.8K- 29.41% |
$483K - $900K
|
165K
$905K
|
|
|
Nov 01, 2024
Q3 2024
|
Easterly Investment Partners LLC
|
SELL
|
- |
-91.5K- 66.98% |
$642K - $1.2M
|
45.1K
$247K
|
|
|
Nov 14, 2024
Q3 2024
|
Voloridge Investment Management, LLC
Jupiter, FL |
SELL
|
- |
-107K- 24.87% |
$750K - $1.4M
|
323K
$1.77M
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-114K- 49.98% |
$798K - $1.49M
|
114K
$624K
|
|
|
Oct 25, 2024
Q3 2024
|
Pinnacle Associates LTD
|
SELL
|
- |
-125K- 42.52% |
$875K - $1.63M
|
169K
$924K
|
|
|
Nov 12, 2024
Q3 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-140K- 44.28% |
$980K - $1.83M
|
176K
$963K
|
|
|
Nov 14, 2024
Q3 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-165K- 11.6% |
$1.16M - $2.16M
|
1.26M
$6.9M
|
|
|
Nov 14, 2024
Q3 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-171K- 54.71% |
$1.2M - $2.24M
|
142K
$778K
|
|
|
Nov 12, 2024
Q3 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-573K- 86.7% |
$4.02M - $7.5M
|
87.9K
$482K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-582K- 41.84% |
$4.08M - $7.61M
|
809K
$4.43M
|
|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-656K- 10.22% |
$4.6M - $8.58M
|
5.76M
$31.6M
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.05M- 87.43% |
$7.37M - $13.7M
|
151K
$827K
|